Showing 3191-3200 of 4166 results for "".
- CVP Partners With Northwest and Central Ohio Ophthalmology Practicehttps://modernod.com/news/cvp-partners-with-northwest-and-central-ohio-ophthalmology-practice/2476202/CEI Vision Partners (CVP) announced that Retina Vitreous Associates (RVA) of Toledo, Ohio is now the newest partner practice to join the CVP platform. RVA is a vitreoretinal surgical practice with nine ophthalmologists who specialize in medical and surgical
- EyeQue Announces Availability of PDCheck on Kickstarter Websitehttps://modernod.com/news/eyeque-announces-availability-of-pdcheck-on-kickstarter-website/2476210/EyeQue, which develops at-home vision tests for smartphones, said this week that its PDCheck tool, a method for measuring pupillary distance (PD), is now available on Kickstarter, according to a
- Millennial Demographics Drive Refractive Surgery Opportunity in UShttps://modernod.com/news/millennial-demographics-drive-refractive-surgery-opportunity-in-us/2479686/Wealth, health, and education are key factors in determining the opportunity for laser vision correction (LVC) procedures in the US, according to new Market Scope data. Refractive procedures are strongly driven by the country’s millennial population, and the high opportunity population is
- Ophthalmologists Implant First Visian Toric ICLs in the UShttps://modernod.com/news/ophthalmologists-implant-first-visian-toric-icls-in-the-us/2479710/Staar Surgical announced the first patient implants of the company’s Visian Toric Implantable Collamer Lenses (TICLs) in the United States by Brinton Vision in St. Louis and Parkhurst NuVision in San Antonio. A select group of lea
- IGF1-Targeting Teprotumumab Tackles Thyroid Eye Diseasehttps://modernod.com/news/igf1-targeting-teprotumumab-tackles-thyroid-eye-disease/2479794/Patients with moderate to severe thyroid-associated ophthalmopathy show significant improvements with treatment with teprotumumab (River Vision Development) extending as far out as 72 weeks, according to a report in Medscape. ̶
- High Dose of Sildenafil Tied to Long-term Retinal Damage in Case Reporthttps://modernod.com/news/high-dose-of-sildenafil-tied-to-long-term-retinal-damage-in-case-report/2479814/A patient who took a high dose of the erectile dysfunction drug sildenafil citrate developed long-term, and possibly irreversible, retinal damage with bilateral multicolored photopsia (perceived flashes of light) and erythropsia (red-tinted vision), according to a
- Ocugen Presents Preclinical Efficacy Data of its Proprietary Nanoemulsion Technology at ARVO 2018https://modernod.com/news/ocugen-presents-preclinical-efficacy-data-of-its-proprietary-nanoemulsion-technology-at-arvo-2018/2480184/Ocugen announced that it presented additional preclinical findings in a poster highlighting the potential efficacy of its unique, patented nanoemulsion formulation of brimonidine tartrate (OCU300) at the Association for Research in Vision and Ophthalmology (ARVO) 2018 Annual Meeting, held
- USC Roski Eye Institute Scientists Present Latest Research at the ARVO Annual Meetinghttps://modernod.com/news/usc-roski-eye-institute-scientists-present-latest-research-at-the-arvo-annual-meeting/2480198/What do nanophotoswitches, lipid nanoparticles, and mapping the brain have in common? They are among the future-forward areas of vision research being investigated by USC Roski Eye Institute
- Eye Health America Acquires Three Optometric Practices in the Pee Dee Region of South Carolinahttps://modernod.com/news/eye-health-america-acquires-three-optometric-practices-in-the-pee-dee-region-of-south-carolina/2478837/Eye Health America (EHA) has added three optometric practices into its business family: David Hamill, OD, and First Vision Group (FVG); Mark Vinson, OD and Vision Care (VC); and David Johnson, OD and Marlboro Eye Care Associates (MECA). All have been providing eye care in Florence, Marion and Ben
- Oertli Launches the ViPer Illuminated Scleral Indentor for Retinal Surgeryhttps://modernod.com/news/oertli-launches-the-viper-illuminated-scleral-indentor-for-retinal-surgery/2477251/Oertli Instrumente announced the launch of the ViPer illuminated scleral indentor, an illuminated indentor for retinal surgery. The ViPer facilitates work in the periphery of the posterior eye segment thanks to its ability to indent and illuminate transsclerally at the same time. Simultan